Latest Commercial Contracts News

Rumble Resources’ latest Scoping Study reveals a promising underground gold mining project at Western Queen South with low capital costs and strong financial returns, setting the stage for rapid development and potential resource expansion.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

HITIQ Ltd has secured a landmark order for its PROTEQT™ mouthguards at the Winter Olympics and launched in the UK consumer market, while advancing global validation and raising over A$2 million in capital.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

RemSense Technologies has secured major contracts with Shell, Chevron, and ExxonMobil while advancing its digital twin platform and recurring revenue base, setting the stage for growth despite near-term cash flow pressures.

Eden Innovations reports solid Q1 FY2026 sales growth with expanding EdenCrete® and OptiBlend® markets, alongside key US property sale developments aimed at debt reduction.

Environmental Clean Technologies Limited is set to acquire exclusive rights to Rice University’s breakthrough Flash Joule Heating technology for PFAS soil remediation, backed by a $3 million capital raise and leadership changes.

Hydrocarbon Dynamics Limited has reactivated its North Sea trial and completed a fully underwritten rights issue raising $718,741, while advancing multiple international projects and exploring new energy ventures.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

1414 Degrees has completed all technical milestones with Woodside, retaining full ownership of its SiBox technology and advancing commercialisation efforts in industrial decarbonisation and hydrogen.